InCred Money has secured Sebi's in-principle approval for a mutual fund licence, marking a key step toward launching its asset management b...

Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged...

India's fair trade regulator CCI has given the green light for TVS Group entities to acquire PGIM India Asset Management. The regulator als...

Indian equities rallied sharply as an interim US-Iran peace framework eased geopolitical concerns and pushed oil prices lower. Improved inf...

Former US President Barack Obama stated that any new deal with Iran is unlikely to be a major improvement over his 2015 nuclear agreement. ...

The U.S. Justice Department has approved Paramount Skydance Corp's massive $110 billion acquisition of Warner Bros. Discovery. This regulat...

Lenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.

A draft deal between Iran and the United States has been published. This agreement could lead to the release of 24 billion dollars in froze...

GNG Electronics witnessed a Rs 175 crore block deal as promoter Vidhi Khandelwal sold shares to domestic mutual funds and foreign investors...

Eyewear retailer Lenskart Solutions experienced a significant block deal valued at Rs 1,862 crore. Abu Dhabi Investment Authority, through ...

In a bold initiative, the Securities and Exchange Board of India (Sebi) is looking to overhaul the reporting standards for executive compen...

Abu Dhabi Investment Authority is set to divest a 2.3% stake in Lenskart for approximately Rs 1,944 crore via a block deal. This follows So...

Sebi has proposed enhanced remuneration disclosure norms for mutual fund asset management companies, including consolidated disclosure of e...

Indian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...

British drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...

UTI AMC's Karthikraj Lakshmanan sees cautiously optimistic Indian market outlook with intact FY27 earnings trajectory, despite near-term cr...